In our field, understanding the long-term performance of cardiovascular devices is critical. Post-market surveillance plays an essential role in this, ensuring we not only track clinical efficacy but also rapidly identify and address safety concerns. I’m curious, how do others integrate this data into their sales strategies?
Integrating real-world data into our sales approach has been key for us. As you said about rapidly addressing safety concerns, I’ve found that sharing updated performance stats with clients strengthens trust and sales. How do you ensure your team stays on top of this data?
Post-market surveillance data can really inform not just patient safety but also how we position our devices in the market. For me, regular updates on device performance help in addressing client concerns proactively; have you found any specific tools or methods that streamline integrating this data into your approach, @don_hawk58?